Vanberra Signal

NextBio

Curated by Signal

NextBio provides a platform to aggregate and interpret large quantities of genomic data for research and clinical applications.

Overview

NextBio, a software company that provides a platform for life science researchers to search, discover and share knowledge across public and proprietary data. The NextBio Platform is an ontology-based semantic framework that connects highly heterogeneous data and textual information. The semantic framework is based on gene, tissue, disease and compound ontologies. The enterprise version of the NextBio platform is being used in life science R&D and drug development by researchers and clinicians at Pharma Companies. It has been acquired by Illumina.

Key facts

Founded
2004

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of therapeutics for biological aging and age-related disease

    Life Sciences TechnologySeattle, United States
  • Provider of a cloud-based bioinformatics platform for biotech research

    Life Sciences TechnologySan Francisco, United States
  • Developer of neural implants to monitor, diagnose and treat the neurological disorders

    Life Sciences TechnologyAlameda, United States

About NextBio

What does NextBio do?

NextBio, a software company that provides a platform for life science researchers to search, discover and share knowledge across public and proprietary data.

Where is NextBio headquartered?

NextBio is headquartered in Santa Clara, United States.

When was NextBio founded?

NextBio was founded in 2004.

Which sector is NextBio in?

NextBio operates in Life Sciences Technology.

Who are NextBio's competitors?

Companies similar to NextBio include Ora Biomedical, Benchling, and Novela Neurotechnologies.